Researchers at Stanford University School of Medicine have proved that a system they developed a few years ago for culturing balls of stem-cell-derived human brain cells, which mimic aspects of real...
According to a recent study, linuron, a herbicide used with other herbicides, insecticides and fungicides to control the growth of grass and weeds, may be an important environmental risk factor in...
GeNeuro, a biopharmaceutical company, developing new treatments for neurological and autoimmune diseases such as multiple sclerosis (MS) and type-1 diabetes, has announced positive safety and...
Researchers from Charité - Universitätsmedizin Berlin have discovered how the body initiates repair mechanisms which will limit the extent of any damage to the myelin sheath caused by multiple...
A recent study of relapsing remitting multiple sclerosis patients treated with fingolimod, natalizumab, or alemtuzumab found they were less likely to convert to secondary progressive MS (SPMS)...
A preliminary study of nonmyeloablative Hematopoietic Stem Cell Transplantation (HSCT) has found it to be more effective than disease-modifying therapy (DMT) for patients with relapsing remitting...
Brain volume loss in multiple sclerosis (MS) is primarily driven by grey matter changes and may be independent of clinically effective treatment, a new study reports.
Brain volume loss is an...
A small molecule, Sephin1, may be able to significantly delay harm to nerve cells caused by multiple sclerosis (MS) a study has shown.
Nerve fibres are wrapped in a sheath of fatty tissue called...
Cardiorespiratory fitness has previously been associated with disease severity, walking capacity and comorbidities in people with multiple sclerosis (MS). However, current evidence is of moderate...
A recent study, which set out to retrospectively determine incidence of pregnancy, disease-modifying therapy (DMT) exposure and pregnancy outcomes in women with relapsing remitting multiple sclerosis...
